Beta
37178

A study on antiviral efficacy of Brucella abortus ether extract against experimental rabies infection in mice

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

The present work deals with Bru-Pel extract in a trial to investigate its effect against rabies virus. The obtained results revealed that Bru-pel has the affinity to induce the highest level of interferon when inoculated 8 hours pre-exposure to rabies infection. However it has no antiviral effect against rabies virus in mice when administrated pre and post-exposure to experimental infection even on zero time. So, it could not be used as post-exposure treatment in case of rabies infection. It was preferable to use specific antiserum with rabies vaccine in emergency cases (post-exposure) for providing the highest rate of protection when administrated on the suitable time (0 to 3 days post-exposure).

DOI

10.21608/jcvr.2015.37178

Keywords

Bru-Pel extract, Brucella, Rabies vaccine and Mice

Authors

First Name

Nermeen

Last Name

Shafik

MiddleName

-

Affiliation

Central Laboratory for Evaluation of Veterinary Biologics, Abassia Cairo, Egypt

Email

-

City

-

Orcid

-

First Name

Hanan

Last Name

Mahmoud

MiddleName

-

Affiliation

Central Laboratory for Evaluation of Veterinary Biologics, Abassia Cairo.

Email

-

City

-

Orcid

-

First Name

A. M.

Last Name

Albehwar

MiddleName

-

Affiliation

Veterinary Serum and Vaccine Research Institute, Abassia Cairo.

Email

behwara@gmail.com

City

-

Orcid

-

Volume

9

Article Issue

1

Related Issue

5756

Issue Date

2015-09-01

Receive Date

2015-06-07

Publish Date

2015-09-01

Page Start

14

Page End

21

Print ISSN

2636-4018

Online ISSN

2636-4026

Link

https://jcvr.journals.ekb.eg/article_37178.html

Detail API

https://jcvr.journals.ekb.eg/service?article_code=37178

Order

3

Type

Original Article

Type Code

799

Publication Type

Journal

Publication Title

Journal of Current Veterinary Research

Publication Link

https://jcvr.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023